Clínica Baviera, S.A. (BME:CBAV)

Clínica Baviera Statistics

Total Valuation

Clínica Baviera has a market cap or net worth of EUR 538.97 million. The enterprise value is 560.53 million.

Market Cap	538.97M
Enterprise Value	560.53M

Important Dates

The next estimated earnings date is Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	Jul 16, 2024

Share Statistics

Clínica Baviera has 15.99 million shares outstanding. The number of shares has decreased by -0.16% in one year.

Current Share Class	n/a
Shares Outstanding	15.99M
Shares Change (YoY)	-0.16%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	1.85%
Owned by Institutions (%)	2.42%
Float	2.15M

Valuation Ratios

The trailing PE ratio is 13.64.

PE Ratio	13.64
Forward PE	n/a
PS Ratio	2.03
PB Ratio	5.48
P/TBV Ratio	9.00
P/FCF Ratio	14.87
P/OCF Ratio	8.59
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.33, with an EV/FCF ratio of 15.46.

EV / Earnings	13.94
EV / Sales	2.11
EV / EBITDA	7.33
EV / EBIT	10.08
EV / FCF	15.46

Financial Position

The company has a current ratio of 0.95, with a Debt / Equity ratio of 0.60.

Current Ratio	0.95
Quick Ratio	0.86
Debt / Equity	0.60
Debt / EBITDA	0.77
Debt / FCF	1.62
Interest Coverage	45.72

Financial Efficiency

Return on equity (ROE) is 43.16% and return on invested capital (ROIC) is 23.45%.

Return on Equity (ROE)	43.16%
Return on Assets (ROA)	17.81%
Return on Invested Capital (ROIC)	23.45%
Return on Capital Employed (ROCE)	34.51%
Revenue Per Employee	155,756
Profits Per Employee	23,567
Employee Count	1,706
Asset Turnover	1.36
Inventory Turnover	46.27

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +19.72% in the last 52 weeks. The beta is 0.68, so Clínica Baviera's price volatility has been lower than the market average.

Beta (5Y)	0.68
52-Week Price Change	+19.72%
50-Day Moving Average	34.39
200-Day Moving Average	33.29
Relative Strength Index (RSI)	47.88
Average Volume (20 Days)	69,254

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Clínica Baviera had revenue of EUR 265.72 million and earned 40.21 million in profits. Earnings per share was 2.47.

Revenue	265.72M
Gross Profit	132.54M
Operating Income	55.65M
Pretax Income	55.99M
Net Income	40.21M
EBITDA	76.53M
EBIT	55.65M
Earnings Per Share (EPS)	2.47

Balance Sheet

The company has 38.58 million in cash and 58.69 million in debt, giving a net cash position of -20.11 million or -1.26 per share.

Cash & Cash Equivalents	38.58M
Total Debt	58.69M
Net Cash	-20.11M
Net Cash Per Share	-1.26
Equity (Book Value)	98.36M
Book Value Per Share	6.06
Working Capital	-2.72M

Cash Flow

In the last 12 months, operating cash flow was 62.76 million and capital expenditures -26.51 million, giving a free cash flow of 36.25 million.

Operating Cash Flow	62.76M
Capital Expenditures	-26.51M
Free Cash Flow	36.25M
FCF Per Share	2.27

Margins

Gross margin is 49.88%, with operating and profit margins of 20.94% and 15.13%.

Gross Margin	49.88%
Operating Margin	20.94%
Pretax Margin	21.07%
Profit Margin	15.13%
EBITDA Margin	28.80%
EBIT Margin	20.94%
FCF Margin	13.64%

Dividends & Yields

This stock pays an annual dividend of 1.57, which amounts to a dividend yield of 4.62%.

Dividend Per Share	1.57
Dividend Yield	4.62%
Dividend Growth (YoY)	20.77%
Years of Dividend Growth	1
Payout Ratio	64.39%
Buyback Yield	0.16%
Shareholder Yield	4.77%
Earnings Yield	7.46%
FCF Yield	6.73%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Clínica Baviera has an Altman Z-Score of 4.93.

Altman Z-Score	4.93
Piotroski F-Score	n/a